IOM model addresses ROI on EHRs

Laura Pedulli | | Health Exec | EMR/EHR

A proposed model released by the Institute of Medicine (IOM) seeks to help hospitals and health systems assess the ROI on EHR adoption.

The model, created by participants from the Digital Learning Collaborative of the IOM Roundtable on Value & Science-Driven Health Care, specifically evaluates institutional investment in EHRs and related technologies to enable inter-organizational comparisons, help identify best implementation approaches and prioritize process redesign efforts.

“Given that most organizations have already invested in health IT to satisfy the requirements of Meaningful Use, the ability to compare the financial returns, or lack thereof, from these projects across organizations has the potential to illuminate opportunities to reduce the ongoing cost of maintaining these systems,” wrote lead author, Julia Adler-Milstein, school of information, University of Michigan, et al.

The report summarizes past case analyses conducted by the Department of Veteran Affairs, Sentara and Kaiser Permanente. Further, the IOM model outlines all stakeholders affected by EHR investment (patients, providers, employers, payers, etc.) as well as a complete list of expense components in EHR implementation and their specific benefits and potential revenue impacts.

View the entire report here.

Laura Pedulli

Related Content

Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care
How are the best in KLAS Health IT vendor rankings created?

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”